Genenta Science (GNTA)

• Market cap: $119M
• 1 day: 91.95%
• 5 days: 94.36%
• 1 month: 96.83%
• 3 months: 62.73%
• 6 months: 58.16%
• Year to date: 36.87%
• 1 year: 15.89%
• 5 years: -43.64%
• 10 years: -43.64%
• Sector: Healthcare
• Industry: Biotechnology

About: Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

Employees: 13